A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2

Background SARS‐CoV‐2 caused one of the most devastating pandemics in the recent history of mankind. Due to various countermeasures, including lock‐downs, wearing masks, and increased hygiene, the virus has been controlled in some parts of the world. More recently, the availability of vaccines, base...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Allergy (Copenhagen) 2022-01, Vol.77 (1), p.243-257
Hauptverfasser:	Mohsen, Mona O., Balke, Ina, Zinkhan, Simon, Zeltina, Villija, Liu, Xuelan, Chang, Xinyue, Krenger, Pascal S., Plattner, Kevin, Gharailoo, Zahra, Vogt, Anne‐Cathrine S., Augusto, Gilles, Zwicker, Marianne, Roongta, Salony, Rothen, Dominik A., Josi, Romano, Costa, Joana J. da, Sobczak, Jan M., Nonic, Aleksandra, Brand, Lee‐Anne, Nuss, Katja, Martina, Byron, Speiser, Daniel E., Kündig, Thomas, Jennings, Gary T., Walton, Senta M., Vogel, Monique, Zeltins, Andris, Bachmann, Martin F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antibodies Antibodies, Neutralizing Antibody Formation Avidity Centrifugation Communicable Disease Control COVID-19 COVID-19 Vaccines Fermentation Humans Hygiene Immunogenicity Mice Original Pandemics Rabbits SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 vaccine Vaccines Vaccines, Virus-Like Particle Viruses virus‐like particles
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!